Actavis UK has rebranded to become Accord Healthcare. The move follows the company’s acquisition by Intas Pharmaceuticals, through its wholly owned subsidiary Accord Healthcare in January 2017.

The combination of the two organisations facilitates the aim for Accord to become the largest generic Pharmaceutical business in the UK and a leading player in the industry at European level.

As part of the rebranding process the Actavis Scheme is being re-launched as the Accord Scheme, which will provide pharmacists with transparent, simple competitive net pricing and ease of use. Pharmacists participating in the Accord Scheme also enjoy the benefit of support from a dedicated account management team who can

tailor the Scheme to pharmacists’ preferred way of purchasing.

In addition to the Accord Scheme, the Accord Academy provides pharmacists and their teams with complimentary online accredited training courses all contributing towards Continuous Professional Development.

‘Our aim remains to work in partnership with our customers, helping them save time and money so they can focus on their important role in the community,’ says Managing Director, Jonathan Wilson. ‘Our field teams and our UK based telemarketing team are committed to offering unparalleled customer service to create a solution that works for pharmacists. The new Accord Scheme gives pharmacists the reassurance of transparent, market-competitive


Once cancer treatment has finished... what happens next? That is the question many people ask once all their active cancer treatment is over. But help is out there. The Transforming Care After Treatment (TCAT) programme is a partnership between the Scottish Government, Macmillan Cancer Support, NHSScotland and local authorities to support a redesign of care following active treatment of cancer. Since the programme started in 2013, it has been making a difference to the lives of hundreds of people across Ayrshire.

‘Once treatment has finished,’ said Caroline Rennie, Macmillan Nurse Consultant, ‘it can take some time for the physical effects of cancer treatment to reduce. Along with the emotional – and often financial – strain of living with cancer, many people feel lost and confused.

‘The TCAT programme aims to support and enable cancer survivors to live as healthy a life as possible for as long as possible. It is all about encouraging self management and getting back to as normal a life as possible. The TCAT programme addresses the issues faced

net prices across our rapidly growing portfolio.

‘As Accord we continue to offer customer’s access to our increasingly large portfolio of medicines underpinned by a strong UK based supply chain across our four UK sites, including the former Actavis UK Manufacturing site in Barnstaple, North Devon. The way we do business and our dedication to our customers remains unchanged.’

Customers who currently use the Actavis scheme will automatically be transferred to the Accord Scheme. To become a member of the Accord scheme, speak to your sales representative or contact the telemarketing team on telephone: 0800 731 0370 or fax: 0800 731 0380.

by patients after their treatment stops. In Ayrshire and Arran, the team use a holistic needs assessment to determine the needs of each individual person. Questions can range from how to keep active and eat healthily, to sleep problems and concerns about sexual relations.

‘By assessing patients at all stages in treatment, we can ensure they receive tailormade information and support to meet their needs. We are currently looking at how we can further develop these clinics.’

If you’re a pharmacist in Ayrshire who has patients who you feel could benefit from this programme, signpost them to Caroline Rennie, Macmillan Nurse Consultant, on 01563 826025.


SURCHARGE Ahead of further cuts to community pharmacy funding, PHOENIX Group has announced that it will not be imposing a fuel surcharge on any of its member pharmacies in the UK, including all Numark members. The decision has been taken in consideration of the financial restrictions that independent community pharmacies are currently facing as a result of the funding cuts.

The additional 7.4 per cent funding cut to the original level of NHS funding received by community pharmacies will be implemented from 1 April 2017, potentially forcing pharmacies to operate with significantly less resource.

‘Independent community pharmacies are under immense pressure right now,’ said Numark Managing Director, John D’Arcy, ‘- the last thing they need is an added financial burden, no matter what the rationale behind that might be.

‘As a business, the main objective of any community pharmacy at the moment is to remain profitable, which can be very difficult if we are not mindful of the challenges facing the sector. At Numark, we are committed to helping them as much as we possibly can by equipping them with the financial and practical support they need in these turbulent times.’

Since the official announcement of the funding cuts in December, Numark has been working to help members combat the foreseeable negative impacts of the funding cuts.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64